Search results for: hypokasja

• DNA-reactive anticancer imidazoacridinone C-1311 is a new inhibitor of hypoxia-inducible factor 1 alpha, vascular endothelial growth factor and tumor angiogenesis

  Publication

  • A. Skwarska
  • J. Paradziej-Łukowicz
  • G. Peszyńska-Sularz
  • A. Brillowska-Dąbrowska
  • J. Konopa

  - ANNALS OF ONCOLOGY - Year 2011

  Hypoxia-inducible factor 1 (HIF-1) plays a critical role for tumor adaptation to hypoxia and promotes angiogenesis. Antitumor imidazoacridinone C-1311 is a DNA reactive topoisomerase II and FLT3 receptor tyrosine kinase inhibitor selected for phase II clinical trials for breast cancer. Here, we demonstrate the new mechanism of C-1311 action involving HIF-1a, vascular endothelial growth factor (VEGF) and angiogenesis as additional...

  Full text to download in external service